DJIA 17,098.45 18.88 0.11%
NASDAQ 4,580.27 22.58 0.50%
S&P 500 2,003.37 6.63 0.33%
market minute promo


company name or ticker
Company Photos
(Click to zoom)

Why Conn's, MeadWestvaco, and Ariad Pharmaceuticals Jumped Today

The stock market managed to climb just enough to set new all-time records again, but these stocks left no doubt of their gains for shareholders. Find out more about what made them soar.

Up 7%: Ariad Gets Good News at Last

Ariad shares jumped today after some positive news from the ASCO conference. Watch below to find out more!

Market Wrap For June 2: Dow, S&P Continue Rising, Nasdaq Slightly Lower

Mid-Afternoon Market Update; ISM Revised Twice, CONN Maintains Gains On Earnings Report

Mid-Afternoon Market Update; ISM Revised Twice, CONN Maintains Gains On Earnings Report

Healthcare Reverse Small Declines Earlier; Ariad Pharma Presents Positive Data For Leukemia Treatmen

Healthcare Reverse Small Declines Earlier; Ariad Pharma Presents Positive Data For Leukemia Treatment

Stocks Recover From Manufacturing Data Snafu as Broadcom Spikes

Ariad's Management Hosts the ARIAD Investor and Analyst Briefing from ASCO Conference (Transcript)

China Data Not Enough to Give Markets Positive June Start

Monday’s Top Biotech Stories: Ariad, Omeros, NPS Pharmaceuticals, and Shire

Ariad, Omeros, NPS Pharmaceuticals, and Shire could all loom large in health care headlines this Monday morning.